You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dolutegravir

Showing 26 - 50 of 330
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Seropositivity, Pregnancy, Tuberculosis Infection Trial in Tembisa (Rifapentine, Isoniazid)

Not yet recruiting
  • HIV Seropositivity
  • +2 more
  • Tembisa, Gauteng, South Africa
    The Aurum Institute: Tembisa Clinical Research Centre
Dec 9, 2022

Severely Immunocompromised HIV Patients Trial in Salvador, Rio de Janeiro, Porto Alegre (Dolutegravir 50 mg, Efavirenz-based

Completed
  • Severely Immunocompromised HIV Patients
  • Dolutegravir 50 mg
  • Efavirenz-based regimens
  • Salvador, Bahia, Brazil
  • +2 more
Mar 15, 2022

HIV Trial in Gaborone (Point-of-Care Cepheid Xpert HIV-1, DTG/ABC/3TC)

Recruiting
  • HIV
  • Gaborone, Botswana
    Botswana Harvard HIV/AIDS Institute Partnership
Jul 5, 2022

HIV-1-infection Trial in Kenya (Dolutegravir)

Completed
  • HIV-1-infection
  • Dolutegravir
  • Kiambu, Kenya
  • +3 more
Jan 26, 2022

HIV Trial in Spain (Dolutegravir 50 MG / Lamivudine 300 MG Oral Tablet [Dovato])

Active, not recruiting
  • HIV Infections
  • Dolutegravir 50 MG / Lamivudine 300 MG Oral Tablet [Dovato]
  • Vigo, Pontevedra, Spain
  • +16 more
Jun 20, 2022

HIV Trial in Worldwide (Dolutegravir 0.5 mg/kg oral suspension, Dolutegravir 5 mg Dispersible Tablets)

Recruiting
  • HIV
  • Dolutegravir 0.5 mg/kg oral suspension
  • Dolutegravir 5 mg Dispersible Tablets
  • Los Angeles, California
  • +17 more
Nov 10, 2022

HIV Trial in Roma (Antiviral Agents)

Not yet recruiting
  • HIV Infections
  • Antiviral Agents
  • Roma, Italy
    Fondazione PoliclinicoAgostino Gemelli IRCCS
Feb 9, 2023

HIV Trial in Cape Town (Doravirine, Dolutegravir)

Not yet recruiting
  • HIV
  • Cape Town, South Africa
    Desmond Tutu Health Foundation
Nov 18, 2022

HIV Infected Population With Latent Tuberculosis Trial run by the CC (rifapentene (RPT), darunavir/cobicistat (DRV/c), Isoniazid

Completed
  • HIV Infected Population With Latent Tuberculosis
  • rifapentene (RPT)
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 15, 2022

HIV Trial in Worldwide (NRTIs, Dolutegravir, Darunavir)

Active, not recruiting
  • HIV Infections
  • Buenos Aires, Ciudad De Buenos Aires, Argentina
  • +27 more
Nov 27, 2022

Virologic Failure and Drug Resistance at and After Switching to

Active, not recruiting
  • Hiv
  • +2 more
    • Lilongwe, Malawi
    • +1 more
    Feb 14, 2022

    Antiretroviral and Related Drugs in Lactating Women and

    Not yet recruiting
    • Lactating Women on Select DOI
    • +2 more
    • Dolutegravir
    • +3 more
    • Botswana, Gaborone, South Africa
    • +3 more
    Jan 19, 2023

    HIV Trial in Bangkok (generic single tablet TAF/FTC/DTG)

    Active, not recruiting
    • HIV
    • generic single tablet TAF/FTC/DTG
    • Bangkok, Thailand
    • +1 more
    Mar 22, 2022

    Dolutegravir Implementation in Sub-Saharan Africa

    Recruiting
    • HIV-1-infection
    • This is an observational study only.
    • Somkele, KwaZulu-Natal, South Africa
    • +1 more
    Feb 15, 2022

    Large Scale Transition toDolutegravir-based First-line ART in

    Not yet recruiting
    • HIV Infections
      • Abidjan, Côte D'Ivoire
      • +2 more
      Mar 28, 2022

      Obesogenic Origins of Maternal and Child Metabolic Health

      Recruiting
      • HIV
      • +4 more
      • Dolutegravir-based antiretroviral therapy
      • Cape Town, South Africa
      • +1 more
      Sep 28, 2021

      HIV-1 Infection Trial in All The Regions Of The Country (40 Centers) (Dolutegravir, Darunavir-cobicistat,

      Completed
      • HIV-1 Infection
      • Dolutegravir
      • +2 more
      • All The Regions Of The Country (40 Centers), France
        (unnamed)
      Jan 3, 2022

      Pediatric HIV Infection Trial in Bangkok (DTG DT 20 mg, DTG DT 25 mg)

      Recruiting
      • Pediatric HIV Infection
      • DTG DT 20 mg
      • DTG DT 25 mg
      • Bangkok, Thailand
        Division of Infectious disease, Department of Pediatrics, Facult
      Nov 15, 2021

      HIV/AIDS Trial in Phnom Penh (Dolutegravir + Darunavir/ritonavir + optimized NRTI)

      Recruiting
      • HIV/AIDS
      • Dolutegravir + Darunavir/ritonavir + optimized NRTI
      • Phnom Penh, Cambodia
        NCHADS
      Aug 25, 2021

      Study Using Real-world Data in Human Immunodeficiency Virus-1

      Recruiting
      • HIV Infections
      • Tuebingen, Baden-Wuerttemberg, Germany
      • +22 more
      Jan 12, 2023

      Effect on HIV Medications on EPC Cells

      Completed
      • AIDS
      • Washington, District of Columbia
        The GW Medical Faculty Associates
      Mar 21, 2022

      HIV Trial in Austin (GSK3640254, DTG, GSK3640254/DTG)

      Completed
      • HIV Infections
      • Austin, Texas
        GSK Investigational Site
      Sep 21, 2021

      HIV, Acute HIV Infection Trial in Chapel Hill, Durham (Dolutegravir 50 mg, Lamivudine 300 mg, Abacavir 600 mg)

      Completed
      Has Results
      • HIV
      • Acute HIV Infection
      • Dolutegravir 50 mg
      • +2 more
      • Chapel Hill, North Carolina
      • +1 more
      Oct 22, 2021

      HIV-1-infection Trial in London (Dolutegravir)

      Not yet recruiting
      • HIV-1-infection
      • Dolutegravir
      • London, United Kingdom
        Chelsea & Westminster Hospital NHS Foundation Trust
      Jun 23, 2021

      Patients' Experiences and Perceptions of 3TC/DTG Dual Therapy

      Active, not recruiting
      • HIV Infections
      • Cultural Domain Analysis
      • +2 more
      • Brighton, United Kingdom
        Royal Sussex County Hospital, Brighton, UK
      May 18, 2022